Decision support for acute ischemic stroke treatment
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is testing a new computer system that helps doctors decide the best way to restore blood flow to the brain after a stroke. The goal is to see if this tool guides treatment choices safely, which may improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) within the last 24 hours.
- You must have been evaluated for treatment to restore blood flow to the brain (clot-busting medicine and/or a procedure to remove the clot).
- You must not have taken part in another study of computer-based decision tools for stroke in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of gentle brain-protecting treatments (temperature, oxygen, positioning, and nerve stimulation) given alongside standard clot-busting therapy for recent strokes. The goal is to see if the combination can help improve recovery and reduce disability after a stroke.
This study tests a structured, fast way of treating people who have a new ischemic stroke (a stroke caused by a blocked blood vessel). It may help because it focuses on getting the right stroke treatments quickly and consistently.
This study looks at patients having a stroke procedure to remove a clot. It aims to predict how well people recover. If you are having this treatment, the study might help doctors understand your likely outcome.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.